DUBLIN, Ireland, Nov. 04, 2016 -- Horizon Pharma plc (Nasdaq:HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, announced today that the company will participate at the following conferences in November:
Global Mizuho Investment Conference
- Date: November 14, 2016
- Location: New York, NY
Stifel Healthcare Conference
- Date: November 15, 2016
- Presentation Time: 8:45 a.m. EST
- Location: New York, NY
Jefferies Autumn 2016 Global Healthcare Conference
- Date: November 17, 2016
- Presentation Time: 1:20 p.m. GMT
- Location: London, United Kingdom
Bank of America Leveraged Finance Conference
- Date: November 29, 2016
- Presentation Time: 7:30 a.m. EST
- Location: Miami, FL
Piper Jaffray Healthcare Conference
- Date: November 29, 2016
- Presentation Time: 8 a.m. EST
- Location: New York, NY
For the above conferences with presentations, they will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com. A replay of the webcasts will be available for the events with presentations.
About Horizon Pharma plc
Horizon Pharma plc is a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. Horizon Pharma markets 11 medicines through its orphan, rheumatology and primary care business units. For more information, please visit www.horizonpharma.com. Follow @HZNPplc on Twitter or view careers on our LinkedIn page.
Contacts: Tina Ventura Senior Vice President, Investor Relations [email protected] U.S. Media: Geoff Curtis Senior Vice President, Corporate Communications [email protected] Ireland Media: Ray Gordon Gordon MRM [email protected]


Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Nvidia and Groq Strike Strategic AI Inference Licensing Deal
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage 



